A ‘triple receptor’ drug originally created to treat type 2 diabetes could be used to treat Alzheimer’s disease after researchers from China and the United Kingdom found it ‘significantly reversed memory loss’ in mice. The research appears in the journal Brain Research. Alzheimer’s disease is a progressive neurodegenerative disease, characterized clinically by progressive memory loss, cognitive decline, and aberrant behavior. In Alzheimer’s,...
